Red Crane Wealth Management »

Lineage Cell Therapeutics In shares owned by Red Crane Wealth Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Red Crane Wealth Management from 13F filings

Historical chart of Red Crane Wealth Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Red Crane Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Red Crane Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $864k 511k 1.69
2025-06-30 $450k 496k 0.91
2025-03-31 $224k 496k 0.45

More positions owned by Red Crane Wealth Management

Aim Etf Products Trust U S Lrgcp 6m Jan (SIXJ)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Innovator Etfs Trust GRWT100 PWR BF (NJAN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Innovator Etfs Trust GRWT100 PWR BF (NAPR)
Innovator Etfs Trust Us Sml Cp Pwr Et (KAPR)
Innovator Etfs Trust Intrnl Dev Jan (IJAN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr Core Div Grwth (DGRO)
Ishares U S Etf Tr Short Duration B (NEAR)

View all positions for Red Crane Wealth Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In